94 related articles for article (PubMed ID: 12147323)
1. Elevated levels of Abeta1-40 and Abeta1-42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice.
Marutle A; Unger C; Hellström-Lindahl E; Wang J; Puoliväli J; Tanila H; Nordberg A; Zhang X
Neurosci Lett; 2002 Aug; 328(3):269-72. PubMed ID: 12147323
[TBL] [Abstract][Full Text] [Related]
2. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
[TBL] [Abstract][Full Text] [Related]
3. Insulin-Like Growth Factor-1 Alleviates Expression of Aβ
Song F; Liu T; Meng S; Li F; Zhang Y; Jiang L
J Mol Neurosci; 2018 Dec; 66(4):595-603. PubMed ID: 30414017
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A
Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554
[TBL] [Abstract][Full Text] [Related]
5. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice.
Wang J; Tanila H; Puoliväli J; Kadish I; van Groen T
Neurobiol Dis; 2003 Dec; 14(3):318-27. PubMed ID: 14678749
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of proteolytic fragments of mutant presenilin 1 and accelerated amyloid deposition are co-regulated in transgenic mice.
Borchelt DR; Lee MK; Gonzales V; Slunt HH; Ratovitski T; Jenkins NA; Copeland NG; Price DL; Sisodia SS
Neurobiol Aging; 2002; 23(2):171-7. PubMed ID: 11804700
[TBL] [Abstract][Full Text] [Related]
8. The Abeta1-42M35C mutated amyloid peptide Abeta1-42 and the 25-35 fragment fail to mimic the subtype-specificity of actions on recombinant human nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4).
Pym LJ; Buckingham SD; Tsetlin V; Boyd CA; Sattelle DB
Neurosci Lett; 2007 Oct; 427(1):28-33. PubMed ID: 17945421
[TBL] [Abstract][Full Text] [Related]
9. Alteration of cortical EEG in mice carrying mutated human APP transgene.
Wang J; Ikonen S; Gurevicius K; van Groen T; Tanila H
Brain Res; 2002 Jul; 943(2):181-90. PubMed ID: 12101040
[TBL] [Abstract][Full Text] [Related]
10. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
Yu WF; Guan ZZ; Bogdanovic N; Nordberg A
Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of neuronal nicotinic acetylcholine receptor channels expressed in Xenopus oocytes by beta-amyloid1-42 peptide.
Lamb PW; Melton MA; Yakel JL
J Mol Neurosci; 2005; 27(1):13-21. PubMed ID: 16055943
[TBL] [Abstract][Full Text] [Related]
12. Selective nicotinic receptor consequences in APP(SWE) transgenic mice.
Bednar I; Paterson D; Marutle A; Pham TM; Svedberg M; Hellström-Lindahl E; Mousavi M; Court J; Morris C; Perry E; Mohammed A; Zhang X; Nordberg A
Mol Cell Neurosci; 2002 Jun; 20(2):354-65. PubMed ID: 12093166
[TBL] [Abstract][Full Text] [Related]
13. The nicotinic alpha7 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice overexpressing human amyloid-beta1-42.
Søderman A; Thomsen MS; Hansen HH; Nielsen EØ; Jensen MS; West MJ; Mikkelsen JD
Brain Res; 2008 Aug; 1227():240-7. PubMed ID: 18619425
[TBL] [Abstract][Full Text] [Related]
14. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphatase STEP61 negatively regulates amyloid β-mediated ERK/CREB signaling pathways via α7 nicotinic acetylcholine receptors.
Zhang L; Xie JW; Yang J; Cao YP
J Neurosci Res; 2013 Dec; 91(12):1581-90. PubMed ID: 24123152
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
[TBL] [Abstract][Full Text] [Related]
17. Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1.
Dewachter I; Van Dorpe J; Smeijers L; Gilis M; Kuipéri C; Laenen I; Caluwaerts N; Moechars D; Checler F; Vanderstichele H; Van Leuven F
J Neurosci; 2000 Sep; 20(17):6452-8. PubMed ID: 10964951
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
[TBL] [Abstract][Full Text] [Related]
19. Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins.
Dineley KT; Xia X; Bui D; Sweatt JD; Zheng H
J Biol Chem; 2002 Jun; 277(25):22768-80. PubMed ID: 11912199
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.
Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z
Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
